Prevalence of HPV infection among men: A systematic review of the literature

Eileen F. Dunne, Carrie Nielson, Katherine M. Stone, Lauri E. Markowitz, Anna R. Giuliano

Research output: Contribution to journalArticle

377 Citations (Scopus)

Abstract

Background. Human papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection; an estimated 6.2 million persons are newly infected every year in the United States. There are limited data on HPV infection in heterosexual men. Methods. We conducted a systematic review of the literature by searching MEDLINE using the terms "human papillomavirus, " "HPV," "male," "seroprevalence," and "serology" to retrieve articles published from 1 January 1990 to 1 February 2006. We included studies that had data on population characteristics and that evaluated male genital anatomic sites or specimens for HPV DNA or included assessments of seropositivity to HPV type 6, 11, 16, or 18 in men. We excluded studies that had been conducted only in children or immunocompromised persons (HIV infected, transplant recipients, or elderly). Results. We included a total of 40 publications on HPV DNA detection and risk factors for HPV in men; 27 evaluated multiple anatomic sites or specimens, 10 evaluated a single site or specimen, and 3 evaluated risk factors or optimal anatomic sites/specimens for HPV detection. Twelve studies assessed site- or specimen-specific HPV DNA detection. HPV prevalence in men was 1.3%-72.9% in studies in which multiple anatomic sites or specimens were evaluated; 15 (56%) of these studies reported ≥20% HPV prevalence. HPV prevalence varied on the basis of sampling, processing methods, and the anatomic site(s) or specimen(s) sampled. We included 15 publications reporting HPV seroprevalence. Rates of seropositivity depended on the population, HPV type, and methods used. In 9 studies that evaluated both men and women, all but 1 demonstrated that HPV seroprevalence was lower in men than in women. Conclusion. HPV infection is highly prevalent in sexually active men and can be detected by use of a variety of specimens and methods. There have been few natural-history studies and no transmission studies of HPV in men. The information that we have reviewed may be useful for future natural-history studies and for modeling the potential impact of a prophylactic HPV vaccine.

Original languageEnglish (US)
Pages (from-to)1044-1057
Number of pages14
JournalJournal of Infectious Diseases
Volume194
Issue number8
DOIs
StatePublished - Oct 15 2006
Externally publishedYes

Fingerprint

Papillomavirus Infections
Seroepidemiologic Studies
Natural History
Publications
DNA
Human papillomavirus 11
Human papillomavirus 6
Papillomavirus Vaccines
Heterosexuality
Population Characteristics
Serology
Sexually Transmitted Diseases

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Prevalence of HPV infection among men : A systematic review of the literature. / Dunne, Eileen F.; Nielson, Carrie; Stone, Katherine M.; Markowitz, Lauri E.; Giuliano, Anna R.

In: Journal of Infectious Diseases, Vol. 194, No. 8, 15.10.2006, p. 1044-1057.

Research output: Contribution to journalArticle

Dunne, Eileen F. ; Nielson, Carrie ; Stone, Katherine M. ; Markowitz, Lauri E. ; Giuliano, Anna R. / Prevalence of HPV infection among men : A systematic review of the literature. In: Journal of Infectious Diseases. 2006 ; Vol. 194, No. 8. pp. 1044-1057.
@article{260119c8d6e8420e9bd09eec3ac5ec11,
title = "Prevalence of HPV infection among men: A systematic review of the literature",
abstract = "Background. Human papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection; an estimated 6.2 million persons are newly infected every year in the United States. There are limited data on HPV infection in heterosexual men. Methods. We conducted a systematic review of the literature by searching MEDLINE using the terms {"}human papillomavirus, {"} {"}HPV,{"} {"}male,{"} {"}seroprevalence,{"} and {"}serology{"} to retrieve articles published from 1 January 1990 to 1 February 2006. We included studies that had data on population characteristics and that evaluated male genital anatomic sites or specimens for HPV DNA or included assessments of seropositivity to HPV type 6, 11, 16, or 18 in men. We excluded studies that had been conducted only in children or immunocompromised persons (HIV infected, transplant recipients, or elderly). Results. We included a total of 40 publications on HPV DNA detection and risk factors for HPV in men; 27 evaluated multiple anatomic sites or specimens, 10 evaluated a single site or specimen, and 3 evaluated risk factors or optimal anatomic sites/specimens for HPV detection. Twelve studies assessed site- or specimen-specific HPV DNA detection. HPV prevalence in men was 1.3{\%}-72.9{\%} in studies in which multiple anatomic sites or specimens were evaluated; 15 (56{\%}) of these studies reported ≥20{\%} HPV prevalence. HPV prevalence varied on the basis of sampling, processing methods, and the anatomic site(s) or specimen(s) sampled. We included 15 publications reporting HPV seroprevalence. Rates of seropositivity depended on the population, HPV type, and methods used. In 9 studies that evaluated both men and women, all but 1 demonstrated that HPV seroprevalence was lower in men than in women. Conclusion. HPV infection is highly prevalent in sexually active men and can be detected by use of a variety of specimens and methods. There have been few natural-history studies and no transmission studies of HPV in men. The information that we have reviewed may be useful for future natural-history studies and for modeling the potential impact of a prophylactic HPV vaccine.",
author = "Dunne, {Eileen F.} and Carrie Nielson and Stone, {Katherine M.} and Markowitz, {Lauri E.} and Giuliano, {Anna R.}",
year = "2006",
month = "10",
day = "15",
doi = "10.1086/507432",
language = "English (US)",
volume = "194",
pages = "1044--1057",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Prevalence of HPV infection among men

T2 - A systematic review of the literature

AU - Dunne, Eileen F.

AU - Nielson, Carrie

AU - Stone, Katherine M.

AU - Markowitz, Lauri E.

AU - Giuliano, Anna R.

PY - 2006/10/15

Y1 - 2006/10/15

N2 - Background. Human papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection; an estimated 6.2 million persons are newly infected every year in the United States. There are limited data on HPV infection in heterosexual men. Methods. We conducted a systematic review of the literature by searching MEDLINE using the terms "human papillomavirus, " "HPV," "male," "seroprevalence," and "serology" to retrieve articles published from 1 January 1990 to 1 February 2006. We included studies that had data on population characteristics and that evaluated male genital anatomic sites or specimens for HPV DNA or included assessments of seropositivity to HPV type 6, 11, 16, or 18 in men. We excluded studies that had been conducted only in children or immunocompromised persons (HIV infected, transplant recipients, or elderly). Results. We included a total of 40 publications on HPV DNA detection and risk factors for HPV in men; 27 evaluated multiple anatomic sites or specimens, 10 evaluated a single site or specimen, and 3 evaluated risk factors or optimal anatomic sites/specimens for HPV detection. Twelve studies assessed site- or specimen-specific HPV DNA detection. HPV prevalence in men was 1.3%-72.9% in studies in which multiple anatomic sites or specimens were evaluated; 15 (56%) of these studies reported ≥20% HPV prevalence. HPV prevalence varied on the basis of sampling, processing methods, and the anatomic site(s) or specimen(s) sampled. We included 15 publications reporting HPV seroprevalence. Rates of seropositivity depended on the population, HPV type, and methods used. In 9 studies that evaluated both men and women, all but 1 demonstrated that HPV seroprevalence was lower in men than in women. Conclusion. HPV infection is highly prevalent in sexually active men and can be detected by use of a variety of specimens and methods. There have been few natural-history studies and no transmission studies of HPV in men. The information that we have reviewed may be useful for future natural-history studies and for modeling the potential impact of a prophylactic HPV vaccine.

AB - Background. Human papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection; an estimated 6.2 million persons are newly infected every year in the United States. There are limited data on HPV infection in heterosexual men. Methods. We conducted a systematic review of the literature by searching MEDLINE using the terms "human papillomavirus, " "HPV," "male," "seroprevalence," and "serology" to retrieve articles published from 1 January 1990 to 1 February 2006. We included studies that had data on population characteristics and that evaluated male genital anatomic sites or specimens for HPV DNA or included assessments of seropositivity to HPV type 6, 11, 16, or 18 in men. We excluded studies that had been conducted only in children or immunocompromised persons (HIV infected, transplant recipients, or elderly). Results. We included a total of 40 publications on HPV DNA detection and risk factors for HPV in men; 27 evaluated multiple anatomic sites or specimens, 10 evaluated a single site or specimen, and 3 evaluated risk factors or optimal anatomic sites/specimens for HPV detection. Twelve studies assessed site- or specimen-specific HPV DNA detection. HPV prevalence in men was 1.3%-72.9% in studies in which multiple anatomic sites or specimens were evaluated; 15 (56%) of these studies reported ≥20% HPV prevalence. HPV prevalence varied on the basis of sampling, processing methods, and the anatomic site(s) or specimen(s) sampled. We included 15 publications reporting HPV seroprevalence. Rates of seropositivity depended on the population, HPV type, and methods used. In 9 studies that evaluated both men and women, all but 1 demonstrated that HPV seroprevalence was lower in men than in women. Conclusion. HPV infection is highly prevalent in sexually active men and can be detected by use of a variety of specimens and methods. There have been few natural-history studies and no transmission studies of HPV in men. The information that we have reviewed may be useful for future natural-history studies and for modeling the potential impact of a prophylactic HPV vaccine.

UR - http://www.scopus.com/inward/record.url?scp=33749631190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749631190&partnerID=8YFLogxK

U2 - 10.1086/507432

DO - 10.1086/507432

M3 - Article

C2 - 16991079

AN - SCOPUS:33749631190

VL - 194

SP - 1044

EP - 1057

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 8

ER -